Proactive Investors - Run By Investors For Investors
Market: AIM
Sector: Pharma & Biotech
Market Cap: 12.03M
Evgen Pharma

Evgen Pharma

Evgen Pharma plc, a clinical stage drug development company focused on the treatment of cancer and neurological conditions.

Evgen Pharma

Interactive graph

col 3
col 4
col 5
col 6

Evgen Pharma Timeline

For a small and undisclosed upfront fee it is licensing the rights to 60 new chemical entities based on the core structure of sulforaphane, the active ingredient in the company's lead product SFX-01 for breast cancer.

© Proactive Investors 2018

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use